Nalaganje...
Sipuleucel-T immunotherapy for castration-resistant prostate cancer. A systematic review and meta-analysis
INTRODUCTION: Sipuleucel-T is a novel active cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer (mCRPC). It is assumed to be associated with less adverse events than conventional docetaxel-based chemotherapy. MATERIAL AND M...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Termedia Publishing House
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3506233/ https://ncbi.nlm.nih.gov/pubmed/23185184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2012.31610 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|